NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Geron Corporation (NASDAQ: GERN ), Hess Corporation (NYSE: HES ), Royal Gold, Inc. (NASDAQ: RGLD ), Lear Corporation (NYSE: LEA ), Menlo Therapeutics Inc. (NASDAQ: MNLO ), and CorEnergy Infrastructure Trust, Inc. (NYSE: CORR ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GERN DOWNLOAD: http://Fundamental-Markets.com/register/?so=GERN HES DOWNLOAD: http://Fundamental-Markets.com/register/?so=HES RGLD DOWNLOAD: http://Fundamental-Markets.com/register/?so=RGLD LEA DOWNLOAD: http://Fundamental-Markets.com/register/?so=LEA MNLO DOWNLOAD: http://Fundamental-Markets.com/register/?so=MNLO CORR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CORR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Geron Corporation (NASDAQ: GERN ), Hess Corporation (NYSE: HES ), Royal Gold, Inc. (NASDAQ: RGLD ), Lear Corporation (NYSE: LEA ), Menlo Therapeutics Inc. (NASDAQ: MNLO ), and CorEnergy Infrastructure Trust, Inc. (NYSE: CORR ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GERON CORPORATION (GERN) REPORT OVERVIEW

Geron's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Geron reported revenue of $0.38MM vs $0.19MM (up 96.34%) and analysts estimated basic earnings per share -$0.04 vs -$0.05. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Geron reported revenue of $1.07MM vs $1.07MM (up 0.09%) and analysts estimated basic earnings per share -$0.15 vs -$0.18. Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is -$0.26 and is expected to report on March 5th, 2020.

To read the full Geron Corporation (GERN) report, download it here: http://Fundamental-Markets.com/register/?so=GERN

-----------------------------------------

HESS CORPORATION (HES) REPORT OVERVIEW

Hess' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Hess reported revenue of $1,539.00MM vs $1,366.00MM (up 12.66%) and analysts estimated basic earnings per share -$0.06 vs -$8.57. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Hess reported revenue of $6,323.00MM vs $5,466.00MM (up 15.68%) and analysts estimated basic earnings per share -$1.10 vs -$13.12. Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.27. The estimated EPS forecast for the next fiscal year is $0.81 and is expected to report on January 29th, 2020.

To read the full Hess Corporation (HES) report, download it here: http://Fundamental-Markets.com/register/?so=HES

-----------------------------------------

ROYAL GOLD, INC. (RGLD) REPORT OVERVIEW

Royal Gold's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Royal Gold reported revenue of $97.59MM vs $114.35MM (down 14.65%) and analysts estimated basic earnings per share $0.36 vs -$0.23. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Royal Gold reported revenue of $459.04MM vs $440.81MM (up 4.14%) and analysts estimated basic earnings per share -$1.73 vs $1.55. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.48. The estimated EPS forecast for the next fiscal year is $1.83 and is expected to report on August 14th, 2019.

To read the full Royal Gold, Inc. (RGLD) report, download it here: http://Fundamental-Markets.com/register/?so=RGLD

-----------------------------------------

LEAR CORPORATION (LEA) REPORT OVERVIEW

Lear's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Lear reported revenue of $4,942.40MM vs $5,363.80MM (down 7.86%) and basic earnings per share $3.47 vs $5.87 (down 40.89%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Lear reported revenue of $21,148.50MM vs $20,467.00MM (up 3.33%) and analysts estimated basic earnings per share $17.35 vs $18.79 (down 7.66%). Analysts expect earnings to be released on April 26th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $5.10. The estimated EPS forecast for the next fiscal year is $19.53 and is expected to report on January 24th, 2020.

To read the full Lear Corporation (LEA) report, download it here: http://Fundamental-Markets.com/register/?so=LEA

-----------------------------------------

MENLO THERAPEUTICS INC. (MNLO) REPORT OVERVIEW

Menlo Therapeutics' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Menlo Therapeutics reported revenue of $0.00MM vs $2.78MM and analysts estimated basic earnings per share -$0.73 vs -$1.80. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Menlo Therapeutics reported revenue of $10.64MM vs $4.58MM (up 132.21%) and analysts estimated basic earnings per share -$2.37 vs -$5.69. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.72. The estimated EPS forecast for the next fiscal year is -$2.48 and is expected to report on February 26th, 2020.

To read the full Menlo Therapeutics Inc. (MNLO) report, download it here: http://Fundamental-Markets.com/register/?so=MNLO

-----------------------------------------

CORENERGY INFRASTRUCTURE TRUST, INC. (CORR) REPORT OVERVIEW

CorEnergy Infrastructure Trust's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, CorEnergy Infrastructure Trust reported revenue of $22.90MM vs $22.40MM (up 2.22%) and analysts estimated basic earnings per share $1.52 vs $0.36 (up 322.22%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, CorEnergy Infrastructure Trust reported revenue of $89.23MM vs $88.75MM (up 0.54%) and analysts estimated basic earnings per share $2.86 vs $2.07 (up 38.16%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.91. The estimated EPS forecast for the next fiscal year is $3.83 and is expected to report on February 26th, 2020.

To read the full CorEnergy Infrastructure Trust, Inc. (CORR) report, download it here: http://Fundamental-Markets.com/register/?so=CORR

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Arden Dalio, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.